Tower Research Capital LLC (TRC) - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 59 filers reported holding APTEVO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$5,000
+400.0%
3,882
+3397.3%
0.00%
Q3 2018$1,000
-92.9%
111
-96.0%
0.00%
-100.0%
Q2 2018$14,000
+1300.0%
2,746
+1544.3%
0.00%
Q1 2018$1,000
-83.3%
167
-87.9%
0.00%
-100.0%
Q4 2017$6,000
+20.0%
1,380
-43.0%
0.00%0.0%
Q2 2017$5,000
-50.0%
2,423
-49.4%
0.00%0.0%
Q1 2017$10,000
+900.0%
4,784
+933.3%
0.00%
Q4 2016$1,0004630.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 974,492$2,495,0000.55%
Perceptive Advisors 988,133$2,530,0000.16%
STRATEGIC INVESTMENT MANAGEMENT, LLC 38,860$99,0000.07%
Laurel Wealth Advisors, Inc. 42,890$110,0000.05%
CSS LLC/IL 353,977$906,0000.04%
GLG Partners LP 396,486$1,015,0000.03%
Capital Impact Advisors, LLC 12,318$32,0000.01%
Spark Investment Management LLC 66,000$168,0000.01%
Peak Asset Management, LLC 10,000$26,0000.01%
OXFORD ASSET MANAGEMENT LLP 99,390$254,0000.01%
View complete list of APTEVO THERAPEUTICS INC shareholders